Results 71 to 80 of about 665 (169)

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort. [PDF]

J Antimicrob Chemother
Vergori A, Cozzi-Lepri A, Lo Caputo S, Tavelli A, Mazzotta V, Schiaroli E, Orofino G, Mussini C, Nozza S, Cingolani A, Antinori A, d'Arminio Monforte A, Icona Foundation Study Group .   +12 more
europepmc   +1 more source

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV. [PDF]

Cancers (Basel), 2023
Greenberg L, Ryom L, Bakowska E, Wit F, Bucher HC, Braun DL, Phillips A, Sabin C, d'Arminio Monforte A, Zangerle R, Smith C, De Wit S, Bonnet F, Pradier C, Mussini C, Muccini C, Vehreschild JJ, Hoy J, Svedhem V, Miró JM, Wasmuth JC, Reiss P, Llibre JM, Chkhartishvili N, Stephan C, Hatleberg CI, Neesgaard B, Peters L, Jaschinski N, Dedes N, Kuzovatova E, Van Der Valk M, Menozzi M, Lehmann C, Petoumenos K, Garges H, Rooney J, Young L, Lundgren JD, Bansi-Matharu L, Mocroft A, On Behalf Of The Respond And D A D Study Groups.   +41 more
europepmc   +1 more source

Chagas disease in Italy: an update of epidemiological studies. [PDF]

Infez Med, 2023
Antinori S, Giacomelli A, Sabaini F, Casalini G, Ridolfo AL.   +4 more
europepmc   +1 more source

Marlon Brando: una icona existencial [PDF]

, 2004
Abstract not ...
openaire  

Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort. [PDF]

J Antimicrob Chemother
Gagliardini R, De Benedittis S, Tavelli A, Lapadula G, Mazzotta V, Bruzzesi E, Cervo A, Carrozzo G, Saracino A, Rusconi S, Marchetti G, Ceccherini-Silberstein F, Antinori A, d'Arminio Monforte A, Muccini C, Icona Foundation Study Group .   +15 more
europepmc   +1 more source

Evaluation of early warning signals for soil erosion using remote sensing indices in northeastern Iran. [PDF]

Sci Rep
Boali A, Hosseinalizadeh M, Kariminejad N, Asgari HR, Mohamadian Behbahani A, Naimi B, Shafaie V, Movahedi Rad M.   +7 more
europepmc   +1 more source

Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation. [PDF]

EClinicalMedicine
Mussini C, Giacomelli A, Quiros-Roldan E, Mazzotta V, Di Biagio A, De Vito A, Costantini A, D'Ettorre G, Giacometti A, Vergori A, Tavelli A, Malagnino V, Castagna A, Chester J, Antinori A, d'Arminio Monforte A, Cozzi-Lepri A, Icona Foundation Cohort Study for the Icona Foundation Study Group.   +17 more
europepmc   +1 more source

Facciamo Luce

And
Il saggio analizza l’affermazione della luce elettrica tra fine Ottocento e prima metà del Novecento attraverso i manifesti pubblicitari dedicati a lampade e sistemi di illuminazione.
Marcello Scalzo
doaj  

Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. [PDF]

Cancers (Basel)
Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Bonnet F, Lundgren J, Bottanelli M, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L, On Behalf Of The D A D And Respond Study Groups.   +25 more
europepmc   +1 more source

Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy. [PDF]

J Antimicrob Chemother
Cozzi-Lepri A, Tavelli A, Taramasso L, Lapadula G, Bobbio N, Piconi S, Guaraldi G, Di Biagio A, Castagna A, Mazzotta V, d'Arminio Monforte A, Icona Foundation Study group .   +11 more
europepmc   +1 more source